# CELECOXIB
> **ANDA211412** · Abbreviated New Drug Application (Generic) · Sponsor: YILING · Approved 2020-03-06
## Drug
- **FDA Application Number:** ANDA211412
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CELECOXIB
- **Generic name:** CELECOXIB
- **Active ingredients:** CELECOXIB
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** YILING
- **Manufacturer:** Chartwell RX, LLC
- **First approval:** 2020-03-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211412)
---
*AI Analytics · CC0 1.0*